176 related articles for article (PubMed ID: 20890664)
1. Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia.
Kleinberg DL; Ameri P; Singh B
Pituitary; 2011 Mar; 14(1):44-52. PubMed ID: 20890664
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial.
Singh B; Smith JA; Axelrod DM; Ameri P; Levitt H; Danoff A; Lesser M; de Angelis C; Illa-Bochaca I; Lubitz S; Huberman D; Darvishian F; Kleinberg DL
Breast Cancer Res; 2014 Nov; 16(6):463. PubMed ID: 25385439
[TBL] [Abstract][Full Text] [Related]
3. SOM230 inhibits insulin-like growth factor-I action in mammary gland development by pituitary independent mechanism: mediated through somatostatin subtype receptor 3?
Ruan W; Fahlbusch F; Clemmons DR; Monaco ME; Walden PD; Silva AP; Schmid HA; Kleinberg DL
Mol Endocrinol; 2006 Feb; 20(2):426-36. PubMed ID: 16223973
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
Chan TW; Pollak M; Huynh H
Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.
Kleinberg DL; Wood TL; Furth PA; Lee AV
Endocr Rev; 2009 Feb; 30(1):51-74. PubMed ID: 19075184
[TBL] [Abstract][Full Text] [Related]
6. Estradiol enhances the stimulatory effect of insulin-like growth factor-I (IGF-I) on mammary development and growth hormone-induced IGF-I messenger ribonucleic acid.
Ruan W; Catanese V; Wieczorek R; Feldman M; Kleinberg DL
Endocrinology; 1995 Mar; 136(3):1296-302. PubMed ID: 7867584
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development.
Ruan W; Kleinberg DL
Endocrinology; 1999 Nov; 140(11):5075-81. PubMed ID: 10537134
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone treatment induces mammary gland hyperplasia in aging primates.
Ng ST; Zhou J; Adesanya OO; Wang J; LeRoith D; Bondy CA
Nat Med; 1997 Oct; 3(10):1141-4. PubMed ID: 9334728
[TBL] [Abstract][Full Text] [Related]
9. IGF-I, GH, and sex steroid effects in normal mammary gland development.
Kleinberg DL; Ruan W
J Mammary Gland Biol Neoplasia; 2008 Dec; 13(4):353-60. PubMed ID: 19034633
[TBL] [Abstract][Full Text] [Related]
10. The effect of GH on estrogen receptor expression in the rat mammary gland.
Feldman M; Ruan W; Tappin I; Wieczorek R; Kleinberg DL
J Endocrinol; 1999 Dec; 163(3):515-22. PubMed ID: 10588825
[TBL] [Abstract][Full Text] [Related]
11. Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development.
Ruan W; Newman CB; Kleinberg DL
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10872-6. PubMed ID: 1438291
[TBL] [Abstract][Full Text] [Related]
12. New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: induction of the local biosynthesis of growth hormone (GH) in the mammary glands of dogs, cats and humans.
Mol JA; van Garderen E; Rutteman GR; Rijnberk A
J Steroid Biochem Mol Biol; 1996 Jan; 57(1-2):67-71. PubMed ID: 8645618
[TBL] [Abstract][Full Text] [Related]
13. Pasireotide (SOM230): development, mechanism of action and potential applications.
Schmid HA
Mol Cell Endocrinol; 2008 May; 286(1-2):69-74. PubMed ID: 17977644
[TBL] [Abstract][Full Text] [Related]
14. Evidence that the mammary fat pad mediates the action of growth hormone in mammary gland development.
Walden PD; Ruan W; Feldman M; Kleinberg DL
Endocrinology; 1998 Feb; 139(2):659-62. PubMed ID: 9449638
[TBL] [Abstract][Full Text] [Related]
15. IGF-I: an essential factor in terminal end bud formation and ductal morphogenesis.
Kleinberg DL; Feldman M; Ruan W
J Mammary Gland Biol Neoplasia; 2000 Jan; 5(1):7-17. PubMed ID: 10791764
[TBL] [Abstract][Full Text] [Related]
16. Effects of food restriction on the responses of the mammary gland and adipose tissue to prolactin and growth hormone in the lactating rat.
Flint DJ; Vernon RG
J Endocrinol; 1998 Feb; 156(2):299-305. PubMed ID: 9518876
[TBL] [Abstract][Full Text] [Related]
17. Pasireotide in Acromegaly: An Overview of Current Mechanistic and Clinical Data.
Samson SL
Neuroendocrinology; 2015; 102(1-2):8-17. PubMed ID: 25792118
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory action on GHRH-induced GH secretion of chronic tamoxifen treatment in breast cancer.
De Marinis L; Mancini A; Izzi D; Bianchi A; Giampietro A; Fusco A; Liberale I; Rossi S; Valle D
Clin Endocrinol (Oxf); 2000 Jun; 52(6):681-5. PubMed ID: 10848871
[TBL] [Abstract][Full Text] [Related]
19. SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile.
Bruns C; Lewis I; Briner U; Meno-Tetang G; Weckbecker G
Eur J Endocrinol; 2002 May; 146(5):707-16. PubMed ID: 11980628
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat.
Murphy LJ; Friesen HG
Endocrinology; 1988 Jan; 122(1):325-32. PubMed ID: 3335211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
